VerifyMe And 3 Other Stocks Under $2 Insiders Are Buying
Portfolio Pulse from Lisa Levin
Insiders at four companies have recently made notable purchases of their own company's stock, signaling potential confidence in their respective companies' futures. SAB Biotherapeutics' Executive Chairman acquired 11,000 shares, following the announcement of dosing trial participants in Australia. Earth Science Tech's CEO bought 230,000 shares after the company reported a net profit for its fiscal second quarter. Butler National's 10% owner purchased 25,272 shares, subsequent to FAA approval for Avcon Industries' modifications in King Air Model B300 Airplanes. VerifyMe's Director acquired 1,800 shares after the company posted upbeat quarterly results. These transactions may influence investors' perspectives on these penny stocks.
December 01, 2023 | 3:23 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
SAB Biotherapeutics' Executive Chairman purchased 11,000 shares, indicating potential insider confidence following the dosing of trial participants in Australia.
The insider purchase combined with the recent positive clinical trial news could lead to increased investor confidence and a potential short-term uptick in the stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
VerifyMe's Director bought 1,800 shares, possibly due to optimism stemming from the company's positive quarterly results.
The insider purchase after upbeat quarterly results may suggest a positive outlook for the company, potentially leading to a short-term positive impact on the stock price.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70